Isocyanates and human health: multistakeholder information needs and research priorities.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 25563538.
- Also identified by DOI 10.1097/JOM.0000000000000278 and PMC identifier 4286799.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To outline the knowledge gaps and research priorities identified by a broad base of stakeholders involved in the planning and participation of an international conference and research agenda workshop on isocyanates and human health held in Potomac, Maryland, in April 2013. A multimodal iterative approach was used for data collection including preconference surveys, review of a 2001 consensus conference on isocyanates, oral and poster presentations, focused break-out sessions, panel discussions, and postconference research agenda workshop. Participants included representatives of consumer and worker health, health professionals, regulatory agencies, academic and industry scientists, labor, and trade associations. Recommendations were summarized regarding knowledge gaps and research priorities in the following areas: worker and consumer exposures; toxicology, animal models, and biomarkers; human cancer risk; environmental exposure and monitoring; and respiratory epidemiology and disease, and occupational health surveillance.
Medical subject headings
- Biomedical Research
- Environmental Monitoring
- Isocyanates
- Neoplasms
- Occupational Diseases
- Occupational Exposure
- Respiratory Tract Diseases